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adenocarcinoma resembling sex cord-stromal
tumor of the ovary: a review of four
postmenopausal cases
Tomomi Katoh1, Masanori Yasuda1*, Kosei Hasegawa2, Eito Kozawa3, Jun-ichi Maniwa4 and Hironobu Sasano5Abstract: The 4 present cases with endometrioid adenocarcinoma (EMA) of the ovary were characterized by
estrogen overproduction and resemblance to sex cord-stromal tumor (SCST). The patients were all postmenopausal,
at ages ranging from 60 to 79 years (av. 67.5), who complained of abdominal discomfort or distention and also
atypical genital bleeding. Cytologically, maturation of the cervicovaginal squamous epithelium and active
endometrial proliferation were detected. The serum estrogen (estradiol, E2) value was preoperatively found to be
elevated, ranging from 48.7 to 83.0 pg/mL (av. 58.4). In contrast, follicle stimulating hormone was suppressed to
below the normal value. MR imaging diagnoses included SCSTs such as granulosa cell tumor or thecoma for 3
cases because of predominantly solid growth, and epithelial malignancy for one case because of cystic and solid
structure. Grossly, the solid part of 3 cases was homogeneously yellow in color. Histologically, varying amounts of
tumor components were arranged in solid nests, hollow tubules, cord-like strands and cribriform-like nests in
addition to the conventional EMA histology.
In summary, postmenopausal ovarian solid tumors with the estrogenic manifestations tend to be preoperatively
diagnosed as SCST. Due to this, in the histological diagnosis, this variant of ovarian EMA may be challenging and
misdiagnosed as SCST because of its wide range in morphology.
Virtual slides: http://www.diagnosticpathology.diagnomx.eu/vs/6096841358065394
Keywords: Ovary, Postmenopausal, Estrogen (E2) overproduction, Endometrioid adenocarcinoma, Resembling sex
cord-stromal tumorIntroduction
Endometrioid adenocarcinoma (EMA) may occur as a
unique variant, irrespective being of ovarian origin or
uterine endometrial origin [1]. The patients with ovarian
tumors often complain variable and unusual symptoms
[2]. Some postmenopausal patients with ovarian tumor
present with atypical genital bleeding. In addition to this
symptom, when endometrial thickening is detected on the
imaging examination, the possibility of estrogen overpro-
duction by the ovarian tumor can be raised. Cervicovagi-
nal cytology also shows an increased maturation of
squamous epithelium due to estrogenic effects [3]. As one* Correspondence: m_yasuda@saitama-med.ac.jp
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reproduction in any medium, provided the orof the most representative ovarian tumors with estrogen
overproduction in postmenopausal women, adult granulose
cell tumor is routinely encountered. Theco-fibromatous
tumor and Brenner tumor arising in postmenopausal
women are also known as having a potential to produce
estrogen more than the normal range.
Since 3 to 4 decades ago, postmenopausal epithelial
ovarian tumors have been found to overproduce estrogen
with considerable frequency [4,5]. According to the cer-
tain reports, mucinous tumor is most frequently charac-
terized by estrogen overproduction [6-8]. In the other
histological types such as serous, endometrioid and clear
cell tumors, however, the recognition for their potential to
overproduce estrogen seems to be less generalized, not
only for pathologists but also for gynecologists.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cluding the serum value of estrogen (E2) and follicle
stimulating hormone (FSH) was performed for solid
ovarian tumors arising in postmenopausal women, espe-
cially when they present with atypical genital bleeding,
endometrial thickening and/or an increased maturation
of squamous epithelium. As a result, 6 cases with ova-
rian EMA having E2 overproduction were encountered
during the last 5 years in our institution. Among them, 4
cases were diagnosed as EMA resembling sex cord-
stromal tumor (SCST). In addition to EMA, a case with
serous adenocarcinoma and 3 cases with clear cell
adenocarcinoma which showed estrogen overproduction
were also experienced. Based on the histological obser-
vation alone, it is less easy to determine whether or not
the ovarian epithelial tumors may overproduce estrogen.
As a tumor marker in the ovarian tumors, estrogen may
have a clinically significant implication [5-7].
Case presentation
The patients were all postmenopausal, aged between 60
and 79 years (av. 67.5). Their chief complaints were
atypical genital bleeding and abdominal distention or
discomfort. Preoperative endocrinological abnormalities
included elevation of serum E2 and suppression of FSH
(Table 1). Cytologically, maturation of squamous epithe-
lium increased on the cervicovaginal smear in 3 cases.Table 1 Clinicopathological presentations
case 1 case 2
age 60 61
menopausal age 52 49
complaint atypical genital bleeding atypical genital bl
a E2 (pg/ml) 52.0 48.7
a FSH (mIU/ml) 4.8 8.4
preoperative diagnosis GCT or thecoma thecoma
treatment TAH, BSO TAH, BSO
FIGO stage IA IA
follow-up NED 48 months NED 38 months
side left left
size (cm) 9x9 10x9
gross solid/yellow solid/yellow
cervicovaginal smear (MI) not available 0/10/90
endometrial smear not available active
SCST components 20% (SCT) 50% (SCT>GCT)
other components - EMAF
endometriosis - +
functioning stroma +++ +
a pre-operative.
FSH: follicle stimulating hormone, TAH: total abdominal hysterectomy, BSO: bilatera
OMT: omentectomy, TC: paclitaxel+ carboplatin, NED: no evidence of desease.
SCST: sex-cord stromal tumor, SCT: Sertori cell tumor, GCT: granulosa cell tumor.
EMAF: endometrioid adenofibroma, MCA: mucinous cystadenofibroma.Active proliferative condition of the endometrium was
detected cytologically in the endometrial smear and histo-
logically in the endometrial biopsy in 3 cases. MR imaging
displayed that the ovarian tumors were predominantly
solid (Figure 1) except for Case 4, in which the tumor was
cystic and solid. Uterine enlargement was demonstrated
in Cases 1, 3 and 4, and the endometrium was thickened
in Cases 2 and 3. Preoperatively, the differential diagnostic
considerations were granulosa cell tumor, thecoma or fi-
broma, and Brenner tumor. All patients underwent total
hysterectomy and bilateral adnexectomy with or without
omentectomy. No lymph node dissection was performed
for any of the patients. Postoperative chemotherapy with
administration of Paclitaxel and Carboplatin was per-
formed for Case 4. All of the patients have taken an un-
eventful clinical course after surgery or chemotherapy
during a period ranging from 7 to 48 months (av. 33). The




The ovarian tumors were all unilateral, and their size
measured from 9 to 16 cm in the great diameter
(Table 1). The cut surface of Cases 1, 2 and 3 was pre-
dominantly solid and homogenously yellow, with focal
necrosis or hemorrhage (Figure 2a), but that of Case 4case 3 case 4
70 79
52 53
eeding abdominal distension no symptom
83.0 50.0
6.9 23.4
GCT or thecoma thecoma, fibroma or Brenner tumor
TAH, BSO, OMT TAH, BSO, OMT, TCx6
IA IC
NED 7 months NED 39 months
right left
16x7 10x8
solid/yellow solid and cystic/gray-white
5/30/65 5/20/75
active not performed
80% (GCT>SCT) 50% (SCT)




Figure 1 T2-enhanced MR imaging demonstrates a solid mass
measuring 14 cm in the great diameter in the pelvic cavity. The
uterus is found to have a thickened endometrium (arrow) and
endocervical glands (arrow head) (Case 3).
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focally solid part (Figure 2b).
Histology
The ovarian tumors showed an admixture of conventional
EMA and components resembling SCST with/without
transition between them. The components resembling
SCST accounted for 20 to 80% of the entire tumor
(Table 1). The histological findings of each tumor were as
follows: Case 1 showed elongated and cord-like or thin
tubules, resembling Sertoli cell tumor, in continuity with
endometrioid components (Figure 3a) and abundant stro-
mal cells with round nuclei and pale cytoplasm, which
were characterized by luteinization (Figure 3b); Case 2
showed small-sized, fused tubular nests resembling Sertoli
cell tumor, accompanied by abundant stroma (Figure 3c),
and solid nests resembling granulosa cell tumor (Figure 3d).
Bland glands resembling endometrial glands, which werea
Figure 2 Cut surface view a (Case 3): The tumor is homogeneously ye
and necrotic. b (Case 4): The majority of the tumor is microcystic and
(arrow).regarded as endometriosis, focally existed; Case 3
showed tubular nests of usual EMA (Figure 3e),
cribriform-like nests simulating Call-Exner bodies
(Figure 3f ), and condensed stroma intervening among
the solid nests; Case 4 showed tubular nests and small-
sized nests or strands (Figure 3h), benign counterparts
of adenofibromatous endometrioid tumor (Figure 3i)
and mucinous cystadenoma (Figure 3j). The presence of
functioning stroma was indicated in Cases 1 (Figure 3)
and 3 (Figure 3g). However, in Cases 2 and 4, the stroma
was less cellular or hyalinized, lacking typical luteinization.
The endocervical glands of the hysterectomy speci-
mens were more activated in the secretion compared to
those in postmenopausal patients with non-estrogen
producing ovarian tumor. The endometrial glands
seemed to be functioning irrespective of the patients’
postmenopausal status. These endocervical and endo-
metrial findings were in concordance with the cyto-
logical findings of the cervicovaginal smear and the
endometrial smear, respectively.
The FIGO stage was determined at IA for Cases 1, 2,
and 3, and IC for Case 4.
Immunohistochemistry
The expressions of CK7 (clone: OV-TL 12/30, 1:50,
Dako, Glostrup, Denmark), epithelial membrane antigen
(clone: E29, 1:50, Dako, Glostrup, Denmark), estrogen
receptor (ER, clone: SP-1, 1:1, Roche, AZ, USA), in-
hibin-α (clone: R1, 1:50, Serotec, Oxford, UK), and ste-
roidogenic factor-1 (SF-1) [9-11] were examined. As a
result, the positive immunoreactions of CK7 (Figure 4a),
epithelial membrane antigen and ER (Figure 4b) were
clearly and massively observed in EMA resembling
SCST as well as in conventional EMA. Inhibin-α
(Figure 4c) was positively observed in the stromal cells
but negatively observed in the epithelial tumor cells. SF-
1 (Figure 4d) expression was abundant in the stromal
cells but was also present to a lesser degree in the epi-
thelial tumor cells.b
llow in color and irregularly lobulated, but focally hemorrhagic






Figure 3 Microscopic findings a (Case 1): Cord-like tubules, mimicking Sertoli cell tumor, are showing a transition with endometrioid
components. b (Case 1): Abundant stromal cells, possessing round nuclei and pale cytoplasm, are characterized by luteinization.
c (Case 2): Small-sized tubular nests, mimicking Sertoli cell tumor, are found to be fused. d (Case 2): Solid nests with no tubular
structure are showing the appearance of granulosa cell tumor. e (Case 3): This area is composed of conventional EMA. f (Case 3):
Large-sized tubular nests with cribriform-like structure mimic the Call-Exner body. g (Case 3): Abundant stroma is rather condensed,
but lacks typical luteinization. h (Case 4): Small-sized nests or strands resemble the features of a Sertoli cell tumor. i (Case 4): A part of
adenofibromatous endometrioid tumor is shown. j (Case 4): The major part of the tumor is composed of mucinous cystadenoma.




Figure 4 Immunohistochemically, the carcinoma cells are clearly positive for CK7 (a), ER (b), while many stromal cells show positive
reaction for inhibin-α (c) (Case 3). Expression of steroid factor-1 (SF-1), which is a transcription factor alternatively termed adrenal
4-binding protein (Ad4BP) to regulate expression of all steroidogenic enzymes [9], is predominant in the stromal cells but minimal in
epithelial cells (Case 1).
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Ovarian EMA has been known for approximately 30 years
to have a histological variant which is characterized by a
resemblance to SCST [12,13], but the precise frequency of
EMA resembling SCST remains to be clarified. According
to Young et al., 8 of 13 cases were initially misdiagnosed
as SCST [12]. A lack of accurate recognition about this
variant may yield a misinterpretation which results in the
misdiagnosis as SCST instead of EMA. Especially, at the
intraoperative diagnosis, both the macroscopic and micro-
scopic findings may mislead pathologists to raise the pos-
sibility of SCST. Although our experience is limited, the 4
present cases were encountered during the last 5 years
since the opening of our institution, accounting for ap-
proximately 10% of the total ovarian EMAs. In fact, Case
1 (Figure 3a, b) was initially diagnosed by the referring
pathologist as Sertoli-Leydig cell tumor with estrogen
overproduction, mainly because of his misinterpreting the
luteinized stromal cells as Leydig cells. One of the critical
differential points between Sertoli-Leydig cell tumor and
EMA is the occurrence age: 28 years for the former and
over 55 years for the latter [12]. But, interestingly, it
should be noted that some Sertoli-Leydig cell tumors con-
tain areas which resemble endometrioid tumor [14]. As
for Case 2 (Figure 3c, d), at the intraoperative diagnosis,
the possible diagnosis of Sertoli cell tumor was made by
the referring pathologist. In this case, the presence of
granulosa cell tumor-like components also may have be-
come a key to misdiagnosis.It has not been pathologically defined as to what part
of the components resembling SCST is supposed to be
contained for the diagnosis of this variant. Reportedly,
the proportions of components resembling SCST in the
entire tumor vary considerably, ranging from 30 to 100%
[15]. In our review, too, the proportions ranged from 20
to 80%. Except for EMA which is almost entirely occu-
pied by the components resembling SCST, as in Case 3
(Figure 3e, f, g), a combination with a variable amount
of conventional EMA would favor the diagnosis of EMA
resembling SCST. Though relatively rare, a coexistence
of cribriform-like nests and solid nests may make it diffi-
cult to lead to the accurate diagnosis of a variant of
EMA. In addition, the histologically reliable hallmarks of
EMA are as follows: squamous differentiation of the
tumor cells, complication of endometriosis within the
tumor or in the background, and transition between
adenofibromatous components of endometrioid type
and carcinoma [12]. In Case 2, endometriosis was specu-
lated to be associated with tumor development. In Case
4 (Figure 3h, i, j), a transition with the benign compo-
nent of adenofibromatous endometrioid tumor was con-
sidered to be strongly supportive of the diagnosis of a
variant of EMA. But, it should be noted that mucinous
cystadenoma may coexist not only in other epithelial
tumors but also in SCSTs. Interestingly, in this case, the
stromal cells were found to be more cellular in the vici-
nity of mucinous cystadenoma rather than within the
endometrioid benign and malignant tumors.
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certain immunohistochemical markers are thought to
contribute greatly to making the diagnosis definite. The
epithelial nature of EMA, in spite of the resemblance to
SCST, could be determined by positive reactions for
CK7 and epithelial membrane antigen [15-17]. Many
EMAs are positive for ER [15] but inconsistently nega-
tive for inhibin-α [15,17]. In the cases with pure SCST,
inhibin-α is frequently expressed, while these epithelial
markers are less frequently or weakly expressed if at all
[15-17], and ER expression is usually negative [18].
The first descriptions about the ovarian functioning
stroma go far back to the 1950s [19]. This stromal
change has been considered to be closely associated with
clinical, biochemical or pathological evidence of endo-
crine function [4-7]. Several investigators demonstrated
that many postmenopausal women with a variable epi-
thelial ovarian tumor would be provided with a potential
to produce more sex steroid hormone represented by es-
trogen than normal postmenopausal women [6-8,20,21].
The frequency of estrogen overproduction is reported to
be over 70% by serological examinations [7,8], and 47%
[4] or 50% [5] by urine analyses. According to some
reports, steroidogenic cells are observed more frequently
in mucinous tumors [6,8,20], and predominantly in post-
menopausal women (80%) [21]. However, the difference
in the incidence of estrogen overproduction among the
variable types of ovarian tumors remains controversial
[22]. Concerning the difference among benign tumor,
borderline malignancy, and malignant tumor, the previ-
ous reports do not seem to present confirmative data be-
cause of their statistically small scale of examined cases
as well as their deviation in histological types [6-8,20,21].
In the report by Young et al., the association between
EMA resembling SCST and estrogenic manifestation or
presence of steroidogenic stroma was described as fol-
lows: 4 of 13 cases had the stroma consistent with that
of luteinized stromal cells, but the evidence of possible
estrogen overproduction was noted in only one case
[12]. There is another description that theca-like stroma
and foci of vacuolated lutein-like cells were noted in one
of 4 cases with EMA [13]. To the best of our knowledge,
with regard to postmenopausal EMA with estrogen over-
production which was confirmed by serological examin-
ation, there have been only 4 reported cases [11,23-25].
These 4 cases included one case with EMA resembling
SCST, and the remaining 3 cases showed conventional
EMA. Based on our limited experience, it is speculated
that EMA resembling SCST may have more estrogenic
manifestations due to the presence of steroidogenic
stroma. Focusing on the source of estrogen overproduction
and its mechanism, in terms of the morpho-functional cor-
relation, immunohistochemical and molecular-based ana-
lyses have been performed [9-11,23,26,27]. Interestingly,Sasano et al. mentioned that SF-1 and steroidogenic
enzymes are expressed in not only stromal cells but also
epithelial tumor cells [10]. However, the association be-
tween clinical hormonal abnormalities and presence or
absence of luteinized stromal cells in ovarian tumor, in-
cluding the relationship with the mechanism of extragona-
dal aromatization, has not been fully established yet [9].
In summary, EMA resembling SCST should be defin-
itely differentiated from SCST from the clinical and
pathological aspects. In order to clarify the significance
of estrogen as a tumor marker for the ovarian tumor
and its utility in the management of the patient, more
precise clinical and pathological data must be gathered.
Furthermore, the molecular-based mechanism with es-
trogen overproduction needs to be explored.
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